Skip to content

Mix & Match! Buy ANY 10 Biomaterial Products, Get 3 Free! Use code Q2BG10 Learn More

GEM 21S^®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More

Bone Substitutes
Membranes
- Geistlich Bio-Gide^®
- RPM™
Matrices
- Geistlich Fibro-Gide^®
- Geistlich Mucograft^®
Bone Harvesting
- Instruments
3D Titanium Scaffold
- Yxoss CBR^®
Membrane Fixation
- MC Bio Supertack
Growth Factors
- GEM 21S^®

Product Support
Young Professionals
Geistlich Guarantee
Geistlich Knowledge Bites Program
Newsroom

GROW
Clinical Resources
Treatment Solutions

Account

Search For:

Clinical Resources

Use the search and filter form below to find informative clinical content by format, therapeutic areas, or product.

FEATURED RESOURCE

Therapeutic Areas
- Major Bone Augmentation(38)
- Minor Bone Augmentation(22)
- Peri-Implantitis(6)
- Periodontal Regeneration(12)
- Ridge Preservation(30)
- Sinus-Floor Elevation(5)
- Soft-Tissue Regeneration(58)
Products
- Geistlich Bio-Gide Shape®(1)
- Geistlich Bio-Gide®(8)
- Geistlich Bio-Oss Collagen®(7)
- Geistlich Bio-Oss®(10)
- Geistlich Fibro-Gide®(33)
- Geistlich Mucograft®(20)
- Geistlich Mucograft® Seal(1)
- GEM 21S®(3)
- vallos®(4)
- vallos®f(1)

Found 58 Results

Initial situation, patient presented with radiographic and clinically traditional signs of peri-implantitis, including bleeding on probing, suppuration, radiographic progressive bone loss and clinical pathologic probing depths.

Mechanical debridement was achieved using titanium scalers, an ultrasonic device with an implant protective cap and titanium brushes to remove all of the visible contaminants of the implant surface. Citric acid was then placed on shreds of a non-woven gauze and applied to the surface for approx. 1min. Copious irrigation was done using saline solution and the surface was ablated using the Er:YAG laser at 20pps/50mj.

After the surface was prepped and no signs of residual granulation tissue was noted, the defect was grafted with Geistlich Bio-Oss®. Attention was given towards not augmenting beyond the bony envelope.

A protective Geistlich Bio-Gide® membrane was placed over Geistlich Bio-Oss®.

Geistlich Fibro-Gide® was placed over Geistlich Bio-Gide® to enhance soft-tissue volume and quality. Geistlich Fibro-Gide® was trimmed and adapted to the defect site ensuring a tension free closure.

Geistlich Fibro-Gide® was place on the top of the bone graft to enhance soft-tissue thickness. Geistlich Fibro-Gide® is porous. We can observe the rapid penetration of blood through the matrix.

Closure with a tension-free flap was achieved by releasing incisions and secured using 4-0 chromic gut sutures.

1.5 year post-operative photo and radiograph show the healing of the soft-tissues with no signs of peri-implantitis and adequate tissue thickening. Radiographic bone levels have maintained stable over the course of the year.

Hanae Saito, DDS, MS, CCRC
Andrew Tong, DDS

BIOBRIEF, Download, Video

Alveolar Ridge Preservation with vallos® Mineralized Cortico-Cancellous Allograft

Video

Download

Preview

Preoperative radiograph of #31 with guarded prognosis due to potential root fracture and infection.

Atraumatic extraction was performed and intact furcation bone is noted.

vallos® mineralized cortico-cancellous bone allograft was placed.

A collagen plug was used to cover the bone allograft

Immediate post alveolar ridge preservation radiograph.

Healing at 2 weeks prior to implant placement.

Healing at 4 months prior to implant placement.

Implant was placed with 32 Ncm. Post implant placement radiograph.

6 months after the implant placement, the final restoration was delivered.

6 months following horizontal ridge augmentation, using Dr. Urban’s sausage technique, we re-entered the site for implant placement using a full thickness flap with no vertical incisions, to not disrupt collateral blood supply. There is excellent bone volume, but a very thin vertical soft tissue volume over the crest of the implant site.

Straumann implants are placed in sites #4 and #5 to a 25Ncm torque value with no issues and the cover screws were placed.

Geistlich Fibro-Gide® is placed crestally over the implants and draped to the buccal and slightly towards the lingual. Geistlich Fibro-Gide® was trimmed slightly to minimize the thickness of the material.

The flap was released so that we can achieve tension-free primary closure over the implant and the Geistlich Fibro-Gide® soft tissue augmentation site.

Following an 8 week healing period, we make a crestal incision and lay a conservative full-thickness flap to uncover the implants. We observe a 3-4 mm increase in verticle soft tissue thickness over the implant site.

We allow 3 weeks following the initial uncovering and can now see beautiful soft tissue architecture surrounding the implants.

Prior to the restorative process we see the pre-restorative radiograph with the healing abutments in place and we can also observe excellent crestal bone levels around the implants.

1 year follow-up. The restorative dentist opted to splint the crowns together. The patient did not want implants posterior to this area and he did not want any sinus augmentation as he had a history of sinus issues.

Dr. Alberto Ortiz-Vigón
Dr. Erik Regidor Correa

BIOBRIEF, Download, Video

Clinical Efficacy of Geistlich Mucograft® in Regeneration of Oral Mucosa Combined with the Surgical Treatment of Peri-implantitis in Implants with Lack of Keratinized Tissue

Video

Download

Preview

Pathological peri-implant pocket depth combined with bleeding on probing.

Partial thickness flap in order to create a periosteal bed free of any muscle attachment and apically positioned.

Implantoplasty of the exposed rough implant surface using burs and silicon carbide polishers.

Xenogeneic collagen matrix structure (Geistlich Mucograft®).

Future position of the xenogeneic collagen matrix facilitated by prosthodontic abutment.

Suture of xenogeneic collagen matrix around the abutment and over the recipient bed.

Buccal view of xenogeneic collagen matrix and apically positioned flap.

Occlusal view of xenogeneic collagen matrix and apically positioned flap.

Lateral view of xenogeneic collagen matrix and apically positioned flap.

Peri-implant tissue health and maintenance of keratinized tissue after one year of surgical treatment.

Periimplant tissue health and maintenance of keratinized tissue after 2 years

A mid-facial incision was made, with the intent to preserve the minimal keratinized tissue that was available, as well as vertical incisions along the line angles of the canines to reflect a partial thickness flap.

Platelet-rich fibrin clots were formed by centrifugation. The leukocyte-PRF (L-PRF) was extracted, and the L-PRF was used to hydrate Geistlich Mucograft®

Geistlich Mucograft® and PRF stabilized via glycolon sutures.

Clinical situation at three-week follow-up.

Occlusal view at twelve-month follow-up.

Frontal view at twelve-month follow-up.

1 - Thin mucosal tissue over implant #7 creating an unesthetic appearance.

2 - Occlusal view of #7 reveals buccal soft-tissue defects.

3 - Augmentation of the soft-tissue on two implant sites, #7 and #10, using a conventional full thickness flap with vertical releasing incisions on site #7 and an envelope flap on site #10.

4 - Geistlich Fibro-Gide® is split into two 3mm thick matrices to be used in both sites, hydrated with sterile saline and trimmed to the defect dimensions.

5 - Geistlich Fibro-Gide® is secured to the periosteum apically and the interproximal papillae with 5-0 chromic gut sutures.

6 - Passive closure of the flap achieved with 6-0 vicryl sutures.

7 - 1 week post-surgery reveals uneventful healing with maintenance of tissue volume.

8 - Buccal view at 8 weeks reveals uneventful healing with maintenance of tissue volume.

9 - Occlusal view at 8 weeks post-surgery.

1 - This case shows a shallow vestibule and almost no keratinized tissue on the lower crestal part. The horizontal incision has to be made within the keratinized tissue (see depicted line).

2 - Ensure the incision is within the keratinized tissue: an apically fixed split flap is used here. Remove the muscles, scar fibers and ligaments before application of Geistlich Mucograft®.

3 - Measure the defect carefully with a periodontal probe and cut Geistlich Mucograft® in a dry state. In the case of a large vestibuloplasty, several pieces of Geistlich Mucograft® can be sutured side by side.

4 - Geistlich Mucograft® is sutured directly onto the periosteum with 5.0 resorbable sutures and left exposed for open healing (healed by secondary intention).

5 - 10 days post-operative: favorable healing where granulation tissue and new soft tissues have formed.

6 - 1 month post-operative: excellent wound healing with complete integration and epithelialization of Geistlich Mucograft® as well as keratinization of the crestal aspect could be observed.

7 - 3 months post-operative: excellent esthetic outcome with full integration and epithelialization of Geistlich Mucograft® to the surrounding tissue and keratinization of the crestal aspect.

8 - 1 year post-operative: the formed keratinized tissue fulfills its functionality and shows an esthetically pleasing result matching the structure and color of the surrounding tissues. The mean width of the peri-implant keratinized mucosa was 4.0 mm, and a low shrinkage was assessed at 38%.

9 - 5 years post-operative: the mucogingival appearance remains stable. The resulting keratinized tissue fulfills its functionality and shows an esthetically pleasing result.

1 - Gingival recessions #23 and #22

3 - 10 week post op healing. Root coverage achieved. Patient reports no problems and is pleased with the results. More follow ups to come.

2 - Sites at the day of the procedure after sutures placed. Tunnel between #23,24 and partial thickness flap raised between #23,22.

Page 1 of 5

Let's Stay Connected. (Enter Email) *

Contact

Geistlich Pharma North America Inc.
400 Alexander Park Drive, Suite 302
Princeton, NJ 08540

Customer Care Toll-free 855-799-5500
[email protected]

Help

Disclaimer
Shipping and Returns
Privacy Policy

Account

Login / Create Account

Company

Geistlich Pharma North America Inc.
Contact

These product(s) and promotion(s) are ONLY available within the North American Dental Markets (US & Canada). Promotions may vary in Canada and Puerto Rico. Please consult our exclusive Canadian distribution partner, HANSAmed Limited, for more details.

CAUTION: Federal law restricts these devices to sale by or on the order of a dentist or physician.

© 2011 - 2025 Geistlich Pharma North America, Inc.